EGFR and familial pancreatic carcinoma: Exogenous MMP-7 treatment has also been reported to promote EGFR-activated MEK signaling, as demonstrated by increase in p-EGFR, p-MEK, and p-ERK in pancreatic cancer cells (Tan et al. 2005).